2013
DOI: 10.1161/jaha.113.000253
|View full text |Cite
|
Sign up to set email alerts
|

The Origin of Human Mesenchymal Stromal Cells Dictates Their Reparative Properties

Abstract: BackgroundHuman mesenchymal stromal cells (hMSCs) from adipose cardiac tissue have attracted considerable interest in regard to cell‐based therapies. We aimed to test the hypothesis that hMSCs from the heart and epicardial fat would be better cells for infarct repair.Methods and ResultsWe isolated and grew hMSCs from patients with ischemic heart disease from 4 locations: epicardial fat, pericardial fat, subcutaneous fat, and the right atrium. Significantly, hMSCs from the right atrium and epicardial fat secret… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
43
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(48 citation statements)
references
References 44 publications
4
43
1
Order By: Relevance
“…From preclinical and translational studies in an acute or subacute ischemic environment, it is known that MSCs act in a multifactorial manner 36-39 . MSCs release anti-fibrotic matrix metaloproteases, modulate cardiac stem cell proliferation and differentiation 9 , stimulate neovascularization 17, 2240 , establish intercellular coupling with cardiomyocytes 41 , mediate Akt-dependant change in calcium and upregulate C×43 42 .…”
Section: Discussionmentioning
confidence: 99%
“…From preclinical and translational studies in an acute or subacute ischemic environment, it is known that MSCs act in a multifactorial manner 36-39 . MSCs release anti-fibrotic matrix metaloproteases, modulate cardiac stem cell proliferation and differentiation 9 , stimulate neovascularization 17, 2240 , establish intercellular coupling with cardiomyocytes 41 , mediate Akt-dependant change in calcium and upregulate C×43 42 .…”
Section: Discussionmentioning
confidence: 99%
“…The recently developed strategy using multipotent stem cells to substitute the damaged cardiomyocytes has been considered as one of the exciting interventions to ameliorate cardiac contractile function [1,2]. While several laboratories have shown functional benefits with transplantation of stem cells derived from either cardiac [3,4] or extra cardiac sources [5][6][7][8], we have recently demonstrated that the stem cells derived from the pericardial adipose tissue (pADSC) favored myogenic differentiation and yielded efficiently cardiac repair in vivo [9], although the mechanistic basis involved remains unclear [10]. Previous experiments have proved that the stem cell-mediated benefits were mediated by the paracrine effects which may involve in releasing growth factors [11] or microRNA [12] and also likely in horizontal gene transfer [13].…”
Section: Introductionmentioning
confidence: 99%
“…Previous experiments have proved that the stem cell-mediated benefits were mediated by the paracrine effects which may involve in releasing growth factors [11] or microRNA [12] and also likely in horizontal gene transfer [13]. Therefore, the therapeutic effectiveness largely depends on the type of donor cells injected [7] and their capability of generating adequate trophic factors.…”
Section: Introductionmentioning
confidence: 99%
“…The cell source-related heterogeneity may not only be related to cell proliferation, clonogenicity, and the potential to differentiate, but also may greatly affect the survivability and behavior after being transplanted into the hostile environment of ischemia, inflammation, proapoptotic factors, and scarring from myocardial infarction [3, 6]. Recently, Naftali-Shani et al .…”
Section: Introductionmentioning
confidence: 99%